/PRNewswire/ BridGene Biosciences, Inc., a biotechnology company that uses proprietary chemoproteomics technology to discover and develop small molecules.
Tessa to prioritize allogeneic CAR-T cell therapy platform following strong safety and efficacy data presented during ASH 2022SINGAPORE, Jan. 03, 2023 (Tessa), a clinical-stage cell therapy company developing
Tessa Therapeutics Provides Strategic Outlook and Corporate Update for 2023 Tessa to prioritize allogeneic CAR-T cell therapy platform following strong safety and efficacy data presented during ASH 2022 GlobeNewswire January 03, 2023 SINGAPORE, Jan. 03, 2023 (GLOBE NEWSWIRE) Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments.
bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company s Scientific and Medical Advisory Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.